100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2009 Research Grants

Gregory J. Hannon, Ph.D.
Genetic Approaches to Therapeutic Targets in Pancreatic Cancer
Cold Spring Harbor Laboratory

Ralph Hruban, M.D.
Sequencing the Familial Pancreatic Cancer Genomes
Johns Hopkins University

Fergus Couch, M.D., Ph.D.
Molecular Charaterization of Precursor Lesions in the Pancreas
Mayo Clinic

Peter Allen, M.D.
Early Detection Project to Develop a Plasma/Cystic Fluid based Test to Detect Pancreatic Cancer
Memorial Sloan Kettering Cancer Center

Scott Lowe, Ph.D.
Investigation of K-ras Effector Pathways in Pancreatic Cancer
Memorial Sloan Kettering Cancer Center

Rosa F. Hwang, M.D.
Wnt Signaling in Pancreatic Cancer Associated Stroma
University of Texas MD Anderson

Tyler Jacks, Ph.D.
Scott Lowe, Ph.D.
Investigation of K-ras Effector Pathways in Pancreatic Cancer
The Koch Institute for Integrative Cancer Research at MIT 
Cold Spring Harbor Laboratory

Thomas Ludwig, Ph.D.
The Role of PALB2/FANCN in the Development of Pancreatic Cancers
Columbia University

Akhilesh Pandey, M.D., Ph.D.
Kinome Profiling to Identify Novel Therapeutic Targets in Pancreatic Cancer
Johns Hopkins University

Bert Vogelstein, M.D.
Early Detection Project to Develop a Plasma/Cystic Fluid Based Test to Detect Pancreatic Cancer
The Development of Novel Diagnostic Approaches for the Early Detection of Pancreatic Neoplasms
Johns Hopkins University

Ralph Steinman, M.D.
Immunotherapy of Pancreatic Cancer by Targeting Mesothelin to Activated Dendritic Cells in Vivo
Rockefeller University

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303